These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 21425270

  • 1. Multiple sclerosis: where will we be in 2020?
    Miller AE.
    Mt Sinai J Med; 2011; 78(2):268-79. PubMed ID: 21425270
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacologic management of multiple sclerosis.
    Blasier MG.
    Urol Nurs; 2008 Jun; 28(3):217-9. PubMed ID: 18605517
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Pharmacological treatment of multiple sclerosis].
    Myhr KM.
    Tidsskr Nor Laegeforen; 2010 Mar 11; 130(5):490-2. PubMed ID: 20224616
    [Abstract] [Full Text] [Related]

  • 6. Cerebrospinal venous insufficiency and multiple sclerosis: investigating the truth.
    Khan O.
    Mult Scler; 2011 May 11; 17(5):511-2. PubMed ID: 21632698
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives.
    Zivadinov R, Ramanathan M, Dolic K, Marr K, Karmon Y, Siddiqui AH, Benedict RH, Weinstock-Guttman B.
    Expert Rev Neurother; 2011 Sep 11; 11(9):1277-94. PubMed ID: 21864074
    [Abstract] [Full Text] [Related]

  • 11. Modern multiple sclerosis treatment - what is approved, what is on the horizon.
    Pilz G, Wipfler P, Ladurner G, Kraus J.
    Drug Discov Today; 2008 Dec 11; 13(23-24):1013-25. PubMed ID: 18775508
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vitamin D as an immune modulator in multiple sclerosis, a review.
    Smolders J, Damoiseaux J, Menheere P, Hupperts R.
    J Neuroimmunol; 2008 Feb 11; 194(1-2):7-17. PubMed ID: 18177949
    [Abstract] [Full Text] [Related]

  • 17. Interferons and multiple sclerosis: is it plausible that beta-IFN treatment could influence the risk of cancer among MS patients?
    Kingwell E, Tremlett H.
    Expert Rev Neurother; 2009 Sep 11; 9(9):1263-5. PubMed ID: 19769440
    [No Abstract] [Full Text] [Related]

  • 18. A new treatment era in multiple sclerosis: clinical applications of new concepts.
    Edan G, Leray E.
    J Neurol Sci; 2011 Jul 15; 306(1-2):170-2. PubMed ID: 20951999
    [Abstract] [Full Text] [Related]

  • 19. A practical guide to pediatric multiple sclerosis.
    Huppke P, Gärtner J.
    Neuropediatrics; 2010 Aug 15; 41(4):157-62. PubMed ID: 21086219
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.